Call Us : 1.919.354.1053

NIRvana Sciences Establishes Synthesis Lab

RESEARCH TRIANGLE PARK, NC, September, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that in addition to its protein conjugation lab, it has also set-up a dye synthesis lab and...
READ MORE

NIRvana Sciences Successfully Closes Series A

RESEARCH TRIANGLE PARK, NC, September 1st, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has successfully closed its Series A investment round. The oversubscribed round...
READ MORE

NIRvana Sciences Awarded SRL from NC Biotech Center

RESEARCH TRIANGLE PARK, NC, July 30th, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has been awarded a $250k Strategic Research Loan from the North Carolina Biotech Center.
READ MORE

NIRvana Sciences Awarded NC Dept. of Commerce Phase I Matching Funds

RESEARCH TRIANGLE PARK, NC, May 18th, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has been awarded a $50k Phase I STTR Matching Grant from the One North Carolina Small...
READ MORE

NIRvana Sciences Welcomes Lisa Cooper to Board of Directors

RESEARCH TRIANGLE PARK, NC, May, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that Lisa Cooper has joined the Board of Directors.  Lisa is owner and VP of PMI Ash and brings...
READ MORE

NIRvana Sciences Wins 2nd NIH Phase I STTR

RESEARCH TRIANGLE PARK, NC, April 30th, 2015– NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, today announced that it has been awarded a second $225k Phase I STTR from NIH’s National Institute of...
READ MORE

NIRvana Sciences Receives Notification of 25th Issued Patent

RESEARCH TRIANGLE PARK, NC, March 17th, 2015– NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, today announced that it had been informed that the 25th patent in its exclusively licensed portfolio had been...
READ MORE

NIRvana Sciences Establishes Conjugation Lab

RESEARCH TRIANGLE PARK, NC, July, 2014 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has set-up a dye conjugation lab and hired cell biologist, Rose Evans-Storms, to its team.
READ MORE

NIRvana Sciences Welcomes Rich West to Board of Directors

RESEARCH TRIANGLE PARK, NC, June, 2014 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that Rich West has joined the Board of Directors.  Rich is CEO of Baebies and brings significant...
READ MORE

NIRvana Sciences Wins NIH Phase I STTR

RESEARCH TRIANGLE PARK, NC, June 13th, 2014– NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins in the field of fluorescent dyes, today announced that it has been awarded a $225k Phase I STTR from NIH’s National Institute of Allergy and Infectious Diseases.
READ MORE
12